PLEASE NOTE: All events are in London (UK) time unless otherwise stated.

Loading Events

« All Events

  • This event has passed.

Forecasting and Data Analytics – China Forecasting: Primary Market Research in China, Market Access and Overcoming Other Challenges in Forecasting

June 23, 2020 @ 9:00 am 9:30 am

Speakers:  Julia Liu and Richard Goosey, Kantar Health

Convenors: Erik Holzinger, groupH & Fritz Meyer, Boehringer Ingelheim

This webinar will provide an insight into the following:

1.            An overview of the regulation changes in China

2.            How the evolution of policies in recent years are mainly to control cost

3.            How regulatory trends on market access have predominantly a positive impact on patients access to medication

4.            The impact of COVID 19

5.            What does the future look like

6.            How do these regulations impact pharma sales

This is a member only event and is free to attend for members.

Julia Liu

Julia Liu

Kantar Health

Prior to Kantar, Julia was the head of HEOR in Becton & Dickinson; Government Affairs Director in Cook Medical; Senior Manager in Bristol Mayer Squibb, and the founder of HEMA, policy & reimbursement manager in Johnson & Johnson Medical China.

She has approximately 15 years of experience in the Life Sciences industry. Her diversified yet connected roles from Government affairs, market access, health economics to outcomes and real-world research has nurtured her extensive experiences with comprehensive stakeholders, including clinical KoLs, Government officials, academic scholars, and hospital managers – global and local. Her experience in such wide-ranging areas has also enriched her insight about evolving policy and implications to the industry, research planning and the capitalisation into environment shaping and business impact, value proposition and assessment for product development.

Richard Goosey

Richard Goosey

Kantar Health

Richard is Chief Methodologist and Senior Director of Advanced Methods for the Kantar Health Division UK. He has 35 years consultancy experience in marketing sciences and advance analytics on both agency and client side. Richard joined Kantar Health from Roche where he specialised in business planning and forecasting in support of the Oncology HER2 franchise. Previously, Richard was at Lundbeck UK where he was Head of Commercial Planning and Business Intelligence. Richard has run the BHBIA and other industry forecasting training courses and has been instrumental in the development of Kantar’s Demand Estimation and Volume Forecasting approaches globally.